Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 393

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 3
Chunk 393
---
    Proceeds
    from exercise of warrants 
     —  
     341,865 
  
    Proceeds
    from private placements 
     2,376,181  
     3,000,000 
  
    Proceeds
    from issuance of promissory notes 
     —  
     3,770,512 
  
    Proceeds
    from notes payable 
     6,977,822  
     4,275,151 
  
    NET
    CASH PROVIDED BY FINANCING ACTIVITIES 
     8,382,772  
     10,517,455 

     Effect
    of exchange rates on cash 
     (135,892) 
     60,141 
  
    NET
    INCREASE (DECREASE) IN CASH 
     (127,767) 
     (1,654,013)

    CASH,
    BEGINNING OF PERIOD 
     220,467  
     1,874,480 

    CASH,
    END OF PERIOD 
    $92,700  
    $220,467 
  
    SUPPLEMENTAL
    DISCLOSURES OF CASH FLOW INFORMATION 

    Cash
    Paid during the year for: 

    Interest 
    $24,555  
    $20,128 
  
    Income
    Taxes 
    $—  
    $— 

    SUPPLEMENTAL
    DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES 

    Contingent
    Shares issued pursuant to Acquisition Agreement 
    $—  
    $— 
  
    Cancellation
    of restricted stock awards 
    $83  
    $— 
  
    Finance
    agreement entered into in exchange for prepaid assets 
    $1,018,930  
    $906,834 
  
    Conversion
    of note payable for issuance of preferred stock 
    $—  
    $2,000,001 
  
    Note
    payable settled through non-cash exercise of warrants 
    $—  
    $2,000,000 
  
    Debt
    discount related to notes payable 
    $24,954  
    $339,342 
  
    Common
    shares issued upon acquisition 
    $6,058,500  
    $136,001,631